Essex Bio-Technology Limited Stock Deutsche Boerse AG
Equities
EB51
KYG312371035
Pharmaceuticals
Sales 2022 | 1.32B 169M 157M 231M | Sales 2023 | 1.71B 218M 203M 299M | Capitalization | 1.41B 181M 168M 247M |
---|---|---|---|---|---|
Net income 2022 | 225M 28.8M 26.78M 39.38M | Net income 2023 | 275M 35.2M 32.73M 48.14M | EV / Sales 2022 | 1.78 x |
Net cash position 2022 | 53.76M 6.88M 6.4M 9.41M | Net cash position 2023 | 221M 28.29M 26.31M 38.68M | EV / Sales 2023 | 0.7 x |
P/E ratio 2022 |
11
x | P/E ratio 2023 |
5.31
x | Employees | 1,481 |
Yield 2022 |
1.55% | Yield 2023 |
3.61% | Free-Float | 45.97% |
Managers | Title | Age | Since |
---|---|---|---|
Hai Zhou Fang
CEO | Chief Executive Officer | 58 | 00-07-30 |
Qi Xue
CTO | Chief Tech/Sci/R&D Officer | 63 | 18-04-08 |
Hian Leng Ngiam
BRD | Director/Board Member | 40 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mia Je Ngiam
FOU | Founder | 70 | 99-01-31 |
Lai Man Yau
BRD | Director/Board Member | 60 | 00-12-31 |
Mee Mooi Yeow
BRD | Director/Board Member | 72 | 04-09-29 |
1st Jan change | Capi. | |
---|---|---|
+6.58% | 41.61B | |
-11.57% | 33.32B | |
+78.45% | 28.8B | |
-14.73% | 15.61B | |
-6.00% | 13.27B | |
-12.55% | 11.46B | |
+166.50% | 10.06B | |
-54.80% | 9.09B | |
+1.27% | 8.9B |